Pușcașu, C.; Negreș, S.; Zbârcea, C.E.; Ungurianu, A.; Ștefănescu, E.; Blebea, N.M.; Chiriță, C.
Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats. Pharmaceuticals 2024, 17, 783.
https://doi.org/10.3390/ph17060783
AMA Style
Pușcașu C, Negreș S, Zbârcea CE, Ungurianu A, Ștefănescu E, Blebea NM, Chiriță C.
Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats. Pharmaceuticals. 2024; 17(6):783.
https://doi.org/10.3390/ph17060783
Chicago/Turabian Style
Pușcașu, Ciprian, Simona Negreș, Cristina Elena Zbârcea, Anca Ungurianu, Emil Ștefănescu, Nicoleta Mirela Blebea, and Cornel Chiriță.
2024. "Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats" Pharmaceuticals 17, no. 6: 783.
https://doi.org/10.3390/ph17060783
APA Style
Pușcașu, C., Negreș, S., Zbârcea, C. E., Ungurianu, A., Ștefănescu, E., Blebea, N. M., & Chiriță, C.
(2024). Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats. Pharmaceuticals, 17(6), 783.
https://doi.org/10.3390/ph17060783
